Combined brachytherapy and ultra-hypofractionated radiotherapy for intermediate-risk prostate cancer: Comparison of toxicity outcomes using a high-dose-rate (HDR) versus low-dose-rate (LDR) brachytherapy boost
Marisa Kollmeier, Daniel Gorovets, Jessica Flynn, Sean M. McBride, Victoria Brennan, Joel Beaudry, Gil’ad N. Cohen, Antonio L. Damato, Zhigang Zhang, Michael J. Zeléfsky
Topics & Concepts
MedicineBrachytherapyProstate cancerGenitourinary systemToxicityCohortCumulative incidenceUrologyCumulative doseNuclear medicineRegimenRadiation therapyInternal medicineCancerProstate Cancer Diagnosis and TreatmentAdvanced Radiotherapy TechniquesProstate Cancer Treatment and Research